Drugs & Pharmaceuticals M&A » By The Online Investor Staff, updated Fri., Jun. 9, 7:22 AM
Recent mergers and acquisitions in the Drugs & Pharmaceuticals M&A category.
| This Slide: #4 of 100 |
Slide #4. Bayer AG — Merck Consumer Care Business
Acquirer:
Bayer AG
Acquiree:
Merck Consumer Care Business (NYSE:MRK)
Details:
Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that it has entered into a definitive agreement to sell its Merck Consumer Care (MCC) business to Bayer AG (BAYRY) for $14.2 billion. Under the terms of the agreement, Bayer AG will acquire Merck's existing OTC business, including the global trademark and prescription rights for Claritin and Afrin.
Open the MRK Page at The Online Investor »
|
||||||||||||||||||||||||
Open the MRK Page at The Online Investor (in a new window) »
 Free MRK Email Alerts:
Get SEC Filing Alerts Get Dividend Alerts 
|
Avg. Broker Rec.
 
|
Strong Buy (3.56 out of 4) 59th percentile
(ranked higher than approx. 59% of all stocks covered)
Analysts' Target Price: MRK Stock Forecast Based on Zacks ABR data; powered by Xignite |
